N-Myc-53BP1 WT pLPC-Puro Citations (13)

Originally described in: 53BP1 promotes non-homologous end joining of telomeres by increasing chromatin mobility.
Dimitrova N, Chen YC, Spector DL, de Lange T Nature. 2008 Oct 19. ():. PubMed Journal

---

Articles Citing N-Myc-53BP1 WT pLPC-Puro

Articles
53BP1 functions as a tumor suppressor in breast cancer via the inhibition of NF-kappaB through miR-146a. Li X, Xu B, Moran MS, Zhao Y, Su P, Haffty BG, Shao C, Yang Q. Carcinogenesis. 2012 Dec;33(12):2593-600. doi: 10.1093/carcin/bgs298. Epub 2012 Oct 1. PubMed
Two- and three-dimensional live cell imaging of DNA damage response proteins. Beckta JM, Henderson SC, Valerie K. J Vis Exp. 2012 Sep 28;(67). pii: 4251. doi: 10.3791/4251. PubMed
RING finger nuclear factor RNF168 is important for defects in homologous recombination caused by loss of the breast cancer susceptibility factor BRCA1. Munoz MC, Laulier C, Gunn A, Cheng A, Robbiani DF, Nussenzweig A, Stark JM. J Biol Chem. 2012 Nov 23;287(48):40618-28. doi: 10.1074/jbc.M112.410951. Epub 2012 Oct 10. PubMed
53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer. Kong X, Ding X, Li X, Gao S, Yang Q. Cancer Sci. 2015 Aug;106(8):982-9. doi: 10.1111/cas.12699. Epub 2015 Jul 14. PubMed
Chemical proteomics reveals a gammaH2AX-53BP1 interaction in the DNA damage response. Kleiner RE, Verma P, Molloy KR, Chait BT, Kapoor TM. Nat Chem Biol. 2015 Oct;11(10):807-14. doi: 10.1038/nchembio.1908. Epub 2015 Sep 7. PubMed
Correlation of Particle Traversals with Clonogenic Survival Using Cell-Fluorescent Ion Track Hybrid Detector. Dokic I, Niklas M, Zimmermann F, Mairani A, Seidel P, Krunic D, Jakel O, Debus J, Greilich S, Abdollahi A. Front Oncol. 2015 Dec 7;5:275. doi: 10.3389/fonc.2015.00275. eCollection 2015. PubMed
Reciprocal Regulation between 53BP1 and the Anaphase-Promoting Complex/Cyclosome Is Required for Genomic Stability during Mitotic Stress. Kucharski TJ, Minshall PE, Moustafa-Kamal M, Turnell AS, Teodoro JG. Cell Rep. 2017 Feb 21;18(8):1982-1995. doi: 10.1016/j.celrep.2017.01.080. PubMed
Combining 53BP1 with BRCA1 as a biomarker to predict the sensitivity of poly(ADP-ribose) polymerase (PARP) inhibitors. Yang ZM, Liao XM, Chen Y, Shen YY, Yang XY, Su Y, Sun YM, Gao YL, Ding J, Zhang A, He JX, Miao ZH. Acta Pharmacol Sin. 2017 Jul;38(7):1038-1047. doi: 10.1038/aps.2017.8. Epub 2017 Apr 17. PubMed
Phase separation of 53BP1 determines liquid-like behavior of DNA repair compartments. Kilic S, Lezaja A, Gatti M, Bianco E, Michelena J, Imhof R, Altmeyer M. EMBO J. 2019 Jul 1:e101379. doi: 10.15252/embj.2018101379. PubMed
betaarrestin-1 regulates DNA repair by acting as an E3-ubiquitin ligase adaptor for 53BP1. Nieto A, Hara MR, Quereda V, Grant W, Saunders V, Xiao K, McDonald PH, Duckett DR. Cell Death Differ. 2020 Apr;27(4):1200-1213. doi: 10.1038/s41418-019-0406-6. Epub 2019 Sep 10. PubMed
Mitochondria-to-nucleus retrograde signaling drives formation of cytoplasmic chromatin and inflammation in senescence. Vizioli MG, Liu T, Miller KN, Robertson NA, Gilroy K, Lagnado AB, Perez-Garcia A, Kiourtis C, Dasgupta N, Lei X, Kruger PJ, Nixon C, Clark W, Jurk D, Bird TG, Passos JF, Berger SL, Dou Z, Adams PD. Genes Dev. 2020 Mar 1;34(5-6):428-445. doi: 10.1101/gad.331272.119. Epub 2020 Jan 30. PubMed
RNF8 has both KU-dependent and independent roles in chromosomal break repair. Tsai LJ, Lopezcolorado FW, Bhargava R, Mendez-Dorantes C, Jahanshir E, Stark JM. Nucleic Acids Res. 2020 Jun 19;48(11):6032-6052. doi: 10.1093/nar/gkaa380. PubMed
Testicular Germ Cell Tumors Acquire Cisplatin Resistance by Rebalancing the Usage of DNA Repair Pathways. Caggiano C, Cavallo F, Giannattasio T, Cappelletti G, Rossi P, Grimaldi P, Feldman DR, Jasin M, Barchi M. Cancers (Basel). 2021 Feb 13;13(4). pii: cancers13040787. doi: 10.3390/cancers13040787. PubMed

If you have published an article using this material, please email us at to have your article added to this page.